Piper Sandler Initiates Coverage On Veracyte with Overweight Rating, Announces Price Target of $66

Benzinga Newsdesk www.benzinga.com Neutral 60.9%

Neg 0% Neu 60.9% Pos 0%

Piper Sandler analyst David Westenberg initiates coverage on Veracyte (NASDAQ:VCYT) with a Overweight rating and announces Price Target of $66.